• Healthcare
  • Good health & well being
Impact category Start-up for good
Degree of maturity
Amount collected : 359,473.02 €
Amount collected
359,473.02 €


Today, in France, more than 10 million people suffer from chronic diseases (cancer, diabetes, cardiovascular diseases). For all these people, physical activity is a non-drug therapy. For example, in cancer treatment, physical activity reduces fatigue by 25% and reduces overall mortality by about 40% (CNIB Data 2017).

Kiplin offers a digital solution, accessible to everyone and everywhere. Each patient is invited to "play" by practising a physical activity adapted to his or her condition. The result: 70% of Kiplin users leave the sedentary threshold.

Based on data, this solution allows health care institutions to analyse the effects of the device on care in a concrete way.

The Kiplin solution is already used in institutions such as the IGR, the Gustave Roussy Institute (1st centre for the fight against cancer in Europe) or the APHP (Assistance Publique des Hôpitaux de Paris).

" style="" > Baafee986e623e902d2951fe651ecd3d

Kiplin offers a digital solution where each patient is invited to "play" by practising a physical activity.

Green arrow 03
Green arrow 05

Documents to download

Lita 07

Regulatory information document

Lita 03

Lita 04

Dossier d'analyse Kiplin - LITA.co

Lita 04

Projet de pacte d'actionnaires

Lita 04

Document d'information règlementaire

Reasons to invest

Risks related to the investment

Transaction conditions


Investment product conditions

Financial product
Minimum ticket
Financial benefit
Legal structure
Company valorization
% of capital reserved for LITA.co investors
Expected exit
Price per share
Amount collected
359,473.02 €
Financial product



Risks: Investing in young companies presents a significant risk of partial or total loss of the invested amount as well as a risk of illiquidity.

This site uses first and third party cookies to provide you with a great user experience, measure audiences and show you personalised ads. By using LITA.co you accept our use of cookies.